how to approach hma failure?
Published 7 years ago • 184 plays • Length 22:13Download video MP4
Download video MP3
Similar videos
-
18:29
aml treatment challenges who, when, and how
-
24:10
when hma fails: newer therapeutic agents for mds
-
19:12
an approach to diagnosis and staging of mds: from morphology to genetics
-
33:47
my approach to mds management
-
3:32
mds: managing hma failure
-
21:55
a unified approach to lower risk mds: standard and emerging therapies
-
47:56
aml diagnosis and treatment 2022
-
57:48
periop medicine series: pulmonary hypertension- preop assessment, optimization and periop management
-
20:01
primary myelofibrosis - overview (presentation, pathophysiology, investigation, treatment)
-
1:39
how do hypomethylating agents work to treat aml? #aml
-
20:13
debate: hypomethylating agents are appropriate in lower-risk mds - only use with caution
-
22:08
a unified approach to higher risk mds: standard and emerging therapies
-
13:24
mutation-based risk stratification approaches in myelofibrosis: any real clinical utility?
-
19:46
venetoclax-based strategies in aml
-
6:52
error management theory
-
19:01
myelodysplastic syndromes: genomic landscape
-
1:00:13
treating mds after hypomethylating agent failure
-
22:41
new opportunities in experimental therapeutics in mds
-
18:38
mutation-based risk stratification approaches in myelofibrosis: any real clinical utility?
-
1:53
constructing safety: reconciling error prevention and error management
-
18:14
novel treatment strategies in low-risk mds: challenges and emerging therapies